Inventor · disambiguated record
Liang Zhou
Also filed as: ZHOU LIANG · ZHOU LIANG-JI
8 granted patents·8 pending applications·355 citations·filing 1992–2025
88Inventor score
Files withJACOBIO PHARMACEUTICALS CO LTD3DANA FABER CANCER INST INC2DANA FARBER CANCER INST INC2CARSGEN LIFE SCIENCES CO LTD1HANGZHOU JIUYUAN GENE ENG CO LTD1
Top patents by PatentIndex Score
16 records- 0196US5849589ACulturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cellsUNIV DUKE·Filed 1996·Granted Dec 15, 1998·258 cites·22 claims
- 0292US11285413B2Manifold assembly and method of usePALL CORP·Filed 2020·Granted Mar 29, 2022·5 cites·8 claims
- 0376US5316920ALymphocyte activation antigen HB15, a member of the immunoglobulin superfamilyDANA FABER CANCER INST INC·Filed 1992·Granted May 31, 1994·33 cites·14 claims
- 0474US6068984AAntibodies to lymphocyte activation antigens and uses thereforDANA FARBER CANCER INST INC·Filed 1998·Granted May 30, 2000·20 cites·6 claims
- 0573US11136320B2Fused ring derivative used as FGFR4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 5, 2021·0 cites·2 claims
- 0671US12315929B2Sodium-chromium-titanium-manganese phosphate self-supporting electrode material, and preparation method therefor and use thereofUNIV WUHAN TECH·Filed 2024·Granted May 27, 2025·0 cites·7 claims
- 0770US5766570ALymphocyte activation antigens and antibodies theretoDANA FARBER CANCER INST INC·Filed 1995·Granted Jun 16, 1998·22 cites·8 claims
- 0868US5710262ANucleic acid encoding HB15 polypeptidesDANA FABER CANCER INST INC·Filed 1994·Granted Jan 20, 1998·17 cites·3 claims
- 0968US2022119386A1Fused ring derivative used as fgfr4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1066US2024261246A1Use of small molecule compound and lenalidomide in preparation of drug for treating multiple myelomaUNIV SOOCHOW·Filed 2024·Application pending·0 cites
- 1161US2025121064A1Gprc5d antibody and use thereofCARSGEN LIFE SCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1258US2025308772A1High-performance cerium-rich misch-metal permanent magnetic material and preparation method thereofUNIV ZHEJIANG·Filed 2025·Application pending·0 cites
- 1358US2021163478A1Fused ring derivative used as fgfr4 inhibitorJACOBIO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1457US2025051754A1Magnetic bead, and preparation method therefor and use thereof in nucleic acid extractionNANJING GENSCRIPT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1552US2024368301A1MONOCLONAL ANTIBODY TARGETING SIRPa AND USE THEREOFHANGZHOU JIUYUAN GENE ENG CO LTD·Filed 2022·Application pending·0 cites
- 1642US2025136702A1Human lifr antigen binding protein, preparation method therefor, and application thereofNONA BIOSCIENCES SUZHOU CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liang Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →